4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery.
作者信息
Kim Chun-Hyung, Leblanc Pierre, Kim Kwang-Soo
机构信息
a Molecular Neurobiology Laboratory , McLean Hospital and Program in Neuroscience, Harvard Medical School , Belmont , MA , USA.
b Paean Biotechnology Inc. , Daejeon , Korea.
出版信息
Expert Opin Drug Discov. 2016;11(4):337-41. doi: 10.1517/17460441.2016.1154529. Epub 2016 Mar 7.
Abstract
摘要
相似文献
1
4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery.用于治疗帕金森病的4-氨基-7-氯喹啉衍生物：对药物发现的启示
Expert Opin Drug Discov. 2016;11(4):337-41. doi: 10.1517/17460441.2016.1154529. Epub 2016 Mar 7.
2
Rational drug discovery design approaches for treating Parkinson's disease.治疗帕金森病的合理药物发现设计方法。
Expert Opin Drug Discov. 2015 Jul;10(7):713-41. doi: 10.1517/17460441.2015.1041495. Epub 2015 Jun 9.
3
Researchers unite to improve Parkinson's drug discovery.研究人员联合起来改进帕金森病药物研发。
Nat Med. 2010 Mar;16(3):247. doi: 10.1038/nm0310-247b.
4
Recent progress in drug discovery for Parkinson's disease.
Curr Top Med Chem. 2015;15(10):905-7. doi: 10.2174/156802661510150328222828.
5
Levodopa: management of Parkinson's disease.左旋多巴：帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S23-37. doi: 10.1002/mds.5558.
6
Parkinson's: treating the symptoms.帕金森病：症状治疗
Br J Nurs. 2011;20(14):852, 854-7. doi: 10.12968/bjon.2011.20.14.852.
7
[Treatment of Parkinson's disease with COMT inhibitors: tolcapone].[用儿茶酚-O-甲基转移酶（COMT）抑制剂治疗帕金森病：托卡朋]
Neurologia. 1998;13 Suppl 1:66-71.
8
[Recent acquisitions in therapy of Parkinson's disease].[帕金森病治疗的近期进展]
Clin Ter. 1981 Nov 30;99(4):401-11.
9
Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson's disease.用于治疗帕金森病的腺苷A(2A)受体拮抗剂的最新发现进展。
Curr Opin Drug Discov Devel. 2010 Jul;13(4):466-80.
10
Novel models for Parkinson's disease and their impact on future drug discovery.帕金森病的新型模型及其对未来药物发现的影响。
Expert Opin Drug Discov. 2018 Mar;13(3):229-239. doi: 10.1080/17460441.2018.1428556. Epub 2018 Jan 24.
引用本文的文献
1
An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.优化后的 Nurr1 激动剂可在帕金森病模型中产生疾病修饰作用。
Nat Commun. 2023 Jul 18;14(1):4283. doi: 10.1038/s41467-023-39970-9.
2
The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.E3 连接酶和 DUB 在神经退行性疾病中的新兴作用。
Mol Neurobiol. 2023 Jan;60(1):247-263. doi: 10.1007/s12035-022-03063-3. Epub 2022 Oct 19.
3
Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.在阿托伐醌-磺胺多辛与阿莫地喹联合用药的安慰剂对照、随机临床试验中出现意外的中枢神经系统安全性信号。
Clin Pharmacol Ther. 2022 Apr;111(4):867-877. doi: 10.1002/cpt.2404. Epub 2021 Sep 14.
4
Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.评估直接结合并调节孤儿核受体 Nurr1 的 NR4A 配体。
J Med Chem. 2020 Dec 24;63(24):15639-15654. doi: 10.1021/acs.jmedchem.0c00894. Epub 2020 Dec 8.
5
The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis.Nurr1作为阿尔茨海默病相关发病机制的介导因子和治疗靶点的关键作用。
Aging Dis. 2020 May 9;11(3):705-724. doi: 10.14336/AD.2019.0718. eCollection 2020 May.
6
PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.PGE1 和 PGA1 与 Nurr1 结合并激活其转录功能。
Nat Chem Biol. 2020 Aug;16(8):876-886. doi: 10.1038/s41589-020-0553-6. Epub 2020 May 25.
7
Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells.Nurr1 的药理学刺激促进成年海马神经干细胞的细胞周期进程。
Int J Mol Sci. 2019 Dec 18;21(1):4. doi: 10.3390/ijms21010004.
8
Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology.迈向充分发掘上市药物的治疗潜力：奥曲肽和氯喹在肿瘤学中的应用
Onco Targets Ther. 2018 Dec 31;12:319-339. doi: 10.2147/OTT.S182685. eCollection 2019.
9
Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.Nurr1（NR4A2）调节 5XFAD 小鼠模型中的阿尔茨海默病相关发病机制和认知功能。
Aging Cell. 2019 Feb;18(1):e12866. doi: 10.1111/acel.12866. Epub 2018 Dec 4.
10
Toward neuroprotective treatments of Parkinson's disease.帕金森病的神经保护治疗
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3795-3797. doi: 10.1073/pnas.1703362114. Epub 2017 Mar 30.
本文引用的文献
1
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.核受体Nurr1激动剂增强其双重功能并改善帕金森病动物模型中的行为缺陷。
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8756-61. doi: 10.1073/pnas.1509742112. Epub 2015 Jun 29.
2
The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.Nurr1激活剂1,1-双（3'-吲哚基）-1-（对氯苯基）甲烷通过抑制核因子κB阻断BV-2小胶质细胞中的炎症基因表达。
Mol Pharmacol. 2015 Jun;87(6):1021-34. doi: 10.1124/mol.114.095398. Epub 2015 Apr 9.
3
A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).一种Nurr1激动剂在由Toll样受体3双链RNA炎性刺激物聚肌胞苷酸（poly(I:C)）引发的帕金森病损伤模型中具有神经保护作用。
PLoS One. 2015 Mar 27;10(3):e0121072. doi: 10.1371/journal.pone.0121072. eCollection 2015.
4
Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.新型对苯基取代二吲哚甲烷在帕金森病小鼠模型中可预防MPTP神经毒性并抑制神经胶质细胞激活。
Toxicol Sci. 2015 Feb;143(2):360-73. doi: 10.1093/toxsci/kfu236. Epub 2014 Nov 17.
5
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.异恶唑并吡啶酮7e（一种Nurr1信号通路的强效激活剂）对小鼠实验性自身免疫性脑脊髓炎的影响。
PLoS One. 2014 Sep 29;9(9):e108791. doi: 10.1371/journal.pone.0108791. eCollection 2014.
6
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons.转录因子 Nurr1 维持多巴胺神经元中的纤维完整性和核编码线粒体基因表达。
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2360-5. doi: 10.1073/pnas.1221077110. Epub 2013 Jan 22.
7
Autophagy modulation as a potential therapeutic target for diverse diseases.自噬调控作为一种治疗多种疾病的潜在靶点。
Nat Rev Drug Discov. 2012 Sep;11(9):709-30. doi: 10.1038/nrd3802.
8
Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease.Nurr1 激活剂对泛素-蛋白酶体系统损伤诱导的帕金森病动物模型的抗帕金森作用。
CNS Neurol Disord Drug Targets. 2012 Sep;11(6):768-73. doi: 10.2174/187152712803581155.
9
Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.结构依赖性激活 NR4A2（Nurr1）通过 1,1-双（3'-吲哚基）-1-（芳基）甲烷类似物在胰腺癌细胞中。
Biochem Pharmacol. 2012 May 15;83(10):1445-55. doi: 10.1016/j.bcp.2012.02.021. Epub 2012 Mar 3.
10
miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression.miR-132 通过直接靶向 Nurr1 表达来调节多巴胺神经元的分化。
J Cell Sci. 2012 Apr 1;125(Pt 7):1673-82. doi: 10.1242/jcs.086421. Epub 2012 Feb 10.
Zotero 插件